Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

'Repeal And Replace' Going Relatively Well For Pharma So Far

Mar 13 2017

• By Cathy Kelly

Capitol House

Related Content

Drug Pricing ‘Solutions’ Coming In Future Phase Of US Healthcare Reform, Sec. Price Says

Mar 08 2017

Shaping A Shkreli Bill: Voucher Abuse Solution May Stumble On FDA Effects

Mar 07 2017

The Drug Pricing Summit Pharma Wasn't Invited To

Mar 09 2017

Bill To Speed ANDA Approvals Gets Cool Reception From Industry, US FDA

Mar 03 2017

GOP Action To Push Through ACA-Replace Bill Threatens Device Tax Repeal

Mar 09 2017

FDA’s Naloxone Product Approval Standards May See Changes

Oct 04 2016

Related Companies

Kaléo Pharmaceutical Inc.

Additional Topics

United States Policy Pricing Debate Elections FDA

More from Pricing Debate

More from Market Access

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window